In the current study, we hypothesized that the loss of responsiveness to GLP-1 contributes to NAFLD disease progression and the beneficial effect of NaB on NAFLD is partially due to its improvement of hepatic GLP-1 sensitivity. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.